Study Evaluating Drug Interaction Between Multiple Doses of Ketoconazole and a Single Dose of SKI-606

Completed · Phase 1

Conditions studied: Healthy

In brief

To investigate a potential pharmacokinetic interaction between SKI-606 and ketoconazole when co-administered.

Key facts

Study ID

NCT00434486

Run by

Wyeth is now a wholly owned subsidiary of Pfizer

People needed

24

Starts

2007-03-01

Expected to finish

2007-03-01

Last updated by the study team

2007-09-12

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Healthy as determined by the investigator on the basis of medical history, physical examination, clinical laboratory test results, vital signs, and 12-lead ECG.

Where it is running

• Study site — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.